Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma.

Urology

Volumn 57, Issue 4, 2001, Pages 675-679

  Gerhards, S ^a   Jung, K ^a   Koenig, F ^a   Daniltchenko, D ^a   Hauptmann, S ^a   Schnorr, D ^a   Loening, S A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENZYMOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGED; AGED, 80 AND OVER; CYSTITIS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

MLCS; MLOWN;

EID: 0035318082     PISSN: None     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/s0090-4295(00)01087-6     Document Type: Article

References (0)